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ABSTRACT
Background Many completed trials of interventions 
for uncomplicated gallstone disease are not as helpful 
as they could be due to lack of standardisation across 
studies, outcome definition, collection and reporting. This 
heterogeneity of outcomes across studies hampers useful 
synthesis of primary studies and ultimately negatively 
impacts on decision making by all stakeholders. Core 
outcome sets offer a potential solution to this problem 
of heterogeneity and concerns over whether the ‘right’ 
outcomes are being measured. One of the first steps in 
core outcome set generation is to identify the range of 
outcomes reported (in the literature or by patients directly) 
that are considered important.
Objectives To develop a systematic map that examines 
the variation in outcome reporting of interventions for 
uncomplicated symptomatic gallstone disease, and 
to identify other outcomes of importance to patients 
with gallstones not previously measured or reported in 
interventional studies.
Results The literature search identified 794 potentially 
relevant titles and abstracts of which 137 were deemed 
eligible for inclusion. A total of 129 randomised controlled 
trials, 4 gallstone disease specific patient- reported 
outcome measures (PROMs) and 8 qualitative studies 
were included. This was supplemented with data from 
6 individual interviews, 1 focus group (n=5 participants) 
and analysis of 20 consultations. A total of 386 individual 
recorded outcomes were identified across the combined 
evidence: 330 outcomes (which were reported 1147 times) 
from trials evaluating interventions, 22 outcomes from 
PROMs, 17 outcomes from existing qualitative studies and 
17 outcomes from primary qualitative research. Areas of 
overlap between the evidence sources existed but also 
the primary research contributed new, unreported in this 
context, outcomes.
Conclusions This study took a rigorous approach to 
catalogue and map the outcomes of importance in 
gallstone disease to enhance the development of the COS 
‘long’ list. A COS for uncomplicated gallstone disease 
that considers the views of all relevant stakeholders is 
needed.
BACKGROUND
Gallstone disease (cholelithiasis) is one of 
the most common gastrointestinal disorders 
worldwide. The prevalence of gallstones is 
approximately 10%–15% in adult popula-
tions and they are more common in women 
and people over the age of 40.1 Approxi-
mately 80% of those affected by gallstone 
disease are asymptomatic and can remain so 
for many years without requiring treatment. 
However, around 20% of patients with gall-
stones become symptomatic and develop 
gallstone- related complications. These 
patients are offered symptom control and/or 
surgical/endoscopic intervention.2 A signifi-
cant number of these patients remain symp-
tomatic only (ie, experiencing pain) without 
developing gallstone- related complications.2
Recommendations from the recent 
National Institute for Health and Care 
Excellence guideline on Gallstone Disease 
Strengths and limitations of this study
 ► This outcome map review is the first to describe the 
heterogeneity in outcome reporting within uncom-
plicated symptomatic gallstone disease.
 ► There is a detailed analysis of all reported outcomes 
from a range of study designs (both primary and 
secondary) reporting outcomes of clinical and/or 
patient relevance.
 ► A mixed- methods approach was used in both col-
lection and analysis of data.
 ► Only studies reported in English language were in-
cluded in the analysis
 ► Quality assessment of included studies was not con-
ducted as the main purpose of the review was to 
extract clinical outcomes not to assess intervention 
effectiveness.
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have clearly demonstrated insufficient information for 
patients with gallstones on the effect of cholecystec-
tomy on patient outcomes.3 The guideline recommends 
‘research is needed to establish the long- term patient 
benefits and harms, so that appropriate information can 
be provided to patients to aid decision- making and long- 
term management of their condition.’3 However, many 
completed trials are not as helpful as they could be due to 
lack of standardisation across studies, outcome definition, 
collection and reporting. This heterogeneity of outcomes 
across studies also hampers useful synthesis of primary 
studies in meta- analyses and ultimately negatively impacts 
on decision making by all stakeholders. In addition to the 
heterogeneity of outcomes currently reported and the 
problems this causes, measuring the wrong outcomes (ie, 
those that are not valued by clinicians or, more impor-
tantly, patients) could also be a real risk for many studies 
if stakeholders are not consulted during the trial design 
process. One way that these problems with heteroge-
neity and relevance to stakeholders can be addressed is 
through the development and use of core outcome sets.4 5 
There is currently no agreed published core outcome set 
for evaluating interventions to treat symptomatic uncom-
plicated gallstone disease.
Core outcome sets (COS) aim to define a minimum 
set of outcomes that should be considered essential for 
the evaluation and reporting of specific interventions or 
conditions (ie, the set of outcomes that should always be 
considered and ideally measured in any evaluation).4 5 
There is a growing body of literature to provide support 
for development of core outcome sets.5 Specifically, 
they are developed using consensus methods involving 
stakeholder groups, such as health professionals and 
patients, so as to ensure that the outcomes being defined 
are both clinically and personally relevant for the indi-
viduals involved.4 5 Assessment of a core outcome set is 
not expected to be mutually exclusive to the measure-
ment of other outcomes. However, a core set will foster 
greater consistency in outcome reporting between studies 
and lead to more meaningful data being available to 
contribute to meta- analysis.4 5 Moreover, core outcome 
sets can minimise the threat of outcome reporting bias 
by ensuring consistency between what is measured and 
what is reported.4 5 Ultimately, they should improve the 
overall efficiency and quality of the evidence on which 
healthcare decisions can be made.
A core outcome set for uncomplicated gallstone disease 
is currently being developed. Details of this project have 
been registered and included in the Core Outcome 
Measures in Effectiveness Trials (COMET) Initiative 
database.6 Outcome mapping is an important step in the 
development of core outcome sets, to present and cata-
logue the outcomes reported to date, and links the liter-
ature review and the subsequent process of consultation 
and consensus.7 Therefore, the objectives of this paper 
are to document the outcome mapping process in the 
development of the core outcome set for symptomatic 
uncomplicated gallstone disease.
METHODS
The protocol for development of the COS is available on 
the COMET website: http://www. comet- initiative. org/ 
studies/ details/ 927? result= true.
Identification of outcomes relevant for symptomatic 
uncomplicated gallstone disease
The identification of outcomes was informed by two 
sources: existing evidence and new primary research. The 
specifics of these are detailed below.
1. Identification of outcomes from existing literature:
a. Outcomes reported in trials of interventions for 
symptomatic uncomplicated gallstone disease.
b. Content analysis of individual items within disease- 
specific patient- reported outcome measures 
(PROMs).
c. Outcomes from exploratory studies reported by 
patients with a lived experience of symptomatic un-
complicated gallstone disease.
2. Identification of outcomes of relevance to patients 
from new primary research.
a. Interviews and focus groups with patients with a 
diagnosis of symptomatic uncomplicated gallstone 
disease and a range of treatments planned or re-
ceived.
b. Audiorecordings of consultations for a clinical trial 
evaluating treatments for symptomatic uncompli-
cated gallstone disease.
Methods for each of these outcome identification stages 
are specified below.
Identification of outcomes from existing literature: 
outcomes reported in trials of interventions for symptomatic 
uncomplicated gallstone disease and identification of disease 
specific PROMs
Reported outcomes of interventions for symptomatic 
uncomplicated gallstone disease were identified by 
updating the search strategy for a recent systematic review 
(Brazzelli et al8; this review included two randomised 
controlled trial, RCTs), by conducting a search for rele-
vant PROMs and by screening the reference lists of rele-
vant Cochrane reviews. In addition, reference lists of 
systematic reviews identified by the search strategy were 
checked for relevant RCTs.
Search methods for identification of studies
Extensive electronic searches were undertaken to identify 
trials for a project on the clinical effectiveness of chole-
cystectomy and these are reported in full elsewhere.8 The 
databases searched included MEDLINE (1946 to week 
37 2012), MEDLINE- in- process (10 September 2012), 
Embase (1974 to 2012 September 10), Science Citation 
Index (1970 to 12 September 2012), BIOSIS (1956 to 
12 September 2012) and the Cochrane Central Register 
of Controlled Trials (Issue 9–12, 2012). Studies iden-
tified from these searches were used to elicit reported 
outcomes. The MEDLINE and EMBASE searches were 
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updated in May 2016 (September 2012–May 2016) to 
identify more recent relevant trials.
In addition, a specific search of MEDLINE and 
EMBASE was undertaken to identify studies that report 
PROM outcome data for cholecystitis, with records 
retrieved by the main search for trials excluded to avoid 
duplication of the results. This search was undertaken in 
May 2016 (1980 to May 2016). The search strategies for 
MEDLINE and EMBASE are reported in online supple-
mental appendix 1. Inclusion criteria for eligible studies 
were as follows; Participants: Adults aged over 18 years 
with symptomatic uncomplicated gallstone disease. Inter-
vention and comparator: Any intervention (surgical or 
non- surgical management, ie, expectant management 
or dietary advice or medical therapy) used to manage 
symptomatic uncomplicated gallstone disease in adults. 
Outcomes: All reported outcomes well eligible for inclu-
sion. Excluded studies included those focusing on asymp-
tomatic gallstone disease or on acute severe cholecystitis, 
cholangitis, or pancreatitis were not considered suitable 
for inclusion. In addition, studies including ‘complex’ 
gallstone cases that is, empyema, ascending cholangitis 
and gallstone ileus, were excluded. Reports published 
in non- English languages for which a translation could 
not be organised were also excluded. In addition, lists of 
included and excluded studies reported in several rele-
vant Cochrane reviews were checked by one reviewer 
(MC) for potentially relevant studies.9–14
Study selection and data extraction
One reviewer (MC) screened all titles and abstracts iden-
tified by the two search strategies and a second reviewer 
(RN) checked a 10% random sample. All full- text papers 
considered potentially eligible were screened by one 
reviewer (MC) and checked by a second reviewer (RN). 
One reviewer (MC) extracted details of all outcomes 
reported (verbatim) and any reported definition of 
outcomes provided by the authors (eg, operating time 
may have been defined and reported by some studies 
as ‘interval between initial skin incision and sin closure’ 
others ‘duration of surgery’ etc. The definition reported 
by study authors was used to when deduplicating items into 
a shorter list. Data were recorded in a Microsoft Excel file. 
A 10% sample was checked by a second reviewer (RN). 
Other relevant data (ie, study and participant characteris-
tics) were extracted by one reviewer (MBe) and checked 
by a second reviewer (MC). At all stages, disagreement 
between reviewers was resolved by discussion.
Data extraction from PROMs
From the list of outcomes reported in trials of interven-
tions for symptomatic uncomplicated gallstone disease 
described above, disease specific PROMS were identi-
fied and supplemented with the studies identified in the 
search. Data were extracted by one reviewer (KG) who 
recorded the name of the PROM(s), the reported PRO 
scales and individual verbatim items. The individual 
verbatim items from each PROM were analysed using 
an inductive content analysis approach and informed 
by previous PROM coding work.15 All PROM items were 
systematically categorised into conceptual health domains 
according to the aspect which they aim to capture. Health 
domains were generated inductively from the identified 
individual items. Domain mapping was conducted two 
authors (KG and JB) independently with any conflicts 
resolved through discussion.
Identification of outcomes from existing literature: outcomes 
reported as important by patients with a lived experience of 
uncomplicated gallstone disease
Search methods for identification of studies
A search for relevant qualitative studies was undertaken 
in August 2016 in the Ovid versions of MEDLINE (from 
1966 to 2016). The search strategies combined search 
terms for cholecystitis, cholecystectomy, with terms for 
qualitative research (online supplemental appendix 1). 
Inclusion criteria included (1) studies that have explored 
(using observations, interviews, focus groups and other 
qualitative methods) participants’ lived experiences of 
gallstones with specific reference to outcomes of impor-
tance. Exclusion criteria included (1) studies that have 
not used qualitative methods; (2) any review articles, 
conference abstracts and those with no full- text articles 
published or non- English language articles.
Study selection and data extraction
One researcher (RN) screened all abstracts and another 
(KG) screening a random 10% sample. Full- text articles 
were obtained for those that were potentially relevant. 
Two researchers (RN and KG) reviewed all potentially 
relevant articles to ensure they met the inclusion criteria. 
To identify additional relevant studies, the reference lists 
of the included studies were also examined.
Data on study characteristics such as author, publica-
tion date, country, focus of investigation, data collec-
tion methods, number of participants and details on 
sample size were extracted. Additionally, two authors 
(KG and RN) independently extracted data from two 
main sources reporting study findings: (1) Direct quotes 
from participants and (2) Authors interpretations of 
participants quotes. These data were recorded verbatim 
and analysed to identify ‘descriptive’ thematic codes. 
Constant comparison method was used to compare find-
ings across studies and an inductive thematic synthesis 
was undertaken to generate a list of themes and sub- 
themes (focused on outcomes) from the data to map 
across the presurgery and postsurgery timeline.16 17 
Throughout this process, the description and wording of 
the themes were continually revised, and notes made as 
to how themes and/or subthemes related and how some 
could be merged. These findings were discussed further 
with the research team to finalise the themes across the 
studies and these were considered, where appropriate, 
as domains relevant for inclusion in the development of 
the COS.









pen: first published as 10.1136/bm




4 Cruickshank M, et al. BMJ Open 2021;11:e045568. doi:10.1136/bmjopen-2020-045568
Open access 
Identification of outcomes of relevance to patients from new 
primary research
In addition to outcomes reported in existing literature, 
we conducted primary qualitative research to further 
inform the identification of outcomes of relevance to 
patients. Three activities were conducted:
1. Interviews with patients with a diagnosis of symptomat-
ic uncomplicated gallstone disease.
2. A focus group with patients who had undergone cho-
lecystectomy.
3. Analysis of audioconsultations from a trial comparing 
surgical versus medical management of symptomatic 
uncomplicated gallstone disease.
Participant identification and invitation
Potential participants for the interviews were identified 
from an ongoing trial comparing laprascopic cholecys-
tectomy with observation/conservative management for 
preventing recurrent symptoms in adutls with uncompli-
cated symptomatic gallstones (CGALL trial). Participants 
were provided with a study participant information leaflet 
(PIL) either in the clinic or posted to the participant if a 
decision about CGALL trial entry was made later.18 The 
PIL contained a detachable reply- slip to complete and 
return to the researcher (in a reply paid envelope) if they 
would like to discuss participating in the interview study. 
Patients being approached to participate in the CGALL 
trial were asked (for trial purposes) if they would consent 
to their consultation being audiorecorded. If consent was 
obtained, these audiorecordings were then analysed for 
the identification of outcomes.
Focus group participants were identified through the 
Scottish Health Research register (SHARE - https://www. 
registerforshare. org/) and sent an invitation letter asking 
them to contact the research team if interested in partici-
pating. Following initial contact, a researcher phoned the 
interested participants and ensured they were clear about 
what the study entailed and arranged a suitable time for 
the focus group.
Data collection, management and analysis
One author (RN) conducted the interviews over the tele-
phone between (April– and August, 2017). The focus 
group was conducted by two members of the trial team 
(KG and the PPI partner BC) on 20 July 2017. Trial 
consultations were conducted as standard and four sites 
across the trial were sampled to inform outcome iden-
tification. Informed (written and recorded) consent 
was obtained from all participants prior to data collec-
tion, and confidentiality of the participants was assured. 
Participants were encouraged to consider what aspects 
of their disease or treatment impacted them most, both 
in terms of physical and psychological functioning and 
what improvements they would wish to see in terms of 
outcomes. Interviews, focus group and audioconsulta-
tions were audiorecorded and transcribed verbatim using 
a professional transcription service. All transcripts were 
imported into NVivo (V.10, 2013: QSR International) and 
analysed using conventional content analysis (ie, coding 
categories are derived directly from the text data and are 
used to interpret meaning from the content).19 Various 
themes and subthemes were generated by one researcher 
(RN) based on the contents of the transcripts to identify 
the outcomes stated by the participants, and these were 
then further discussed (with KG) to finalise the list of 
outcomes identified across the primary qualitative data. 
The analysis was oriented to address the aim of identi-
fying the range of outcomes that might be considered 
important and the reasons used to justify assessment of 
them as important.
Categorisation of identified outcomes into outcome domains
The list of potential outcomes generated from the system-
atic evidence search and primary qualitative research 
formed the basis of a ‘long’ list of outcomes used to refine 
the items into a final ‘short’ list for inclusion in the Delphi 
stage of core outcome set development. Outcomes were 
first grouped and reduced according to original source, 
that is, the initial long list from the evidence review was 
reduced for duplication by two members of the research 
team (MC and IA). A similar process was conducted to 
deduplicate the outcomes identified from the PROM 
coding, qualitative evidence synthesis and primary qual-
itative research (KG and RN). These outcomes lists were 
then merged to identify areas of overlap and reduce 
for further duplication through iterative group discus-
sions (further addressing duplications and relevance of 
outcomes for effectiveness trials) to produce a final short 
list OF individual outcomes of relevance in this context.
Individual outcome items were further grouped into 
broader concept level headings to categorise outcome 
domains. These concept- level headings were informed by 
other outcome categorisation work in the area of COS 
and supplemented through study management group 
discussion. The categorisation was performed by one 
member of the team (KG) and refined through iterative 
discussions.15 20 21
Patient and public involvement
The outcome mapping work reported in this manu-
script has involved the input of patients from inception, 
through design, conduct and reporting. Coauthor BC 
is a patient partner and has been involved in all phases 
of project design and delivery and specifically helped to 
facilitate the patient focus groups to identify outcomes of 
importance to patients.
RESULTS
Studies identified from the search of existing literature
The literature search identified 794 (633 from the search 
of trials, 60 from the PROM search and 101 from the 
search of qualitative literature) potentially relevant titles 
and abstracts for screening. Of these, 137 (129 from 
trials and PROMs and 8 qualitative studies) were deemed 
eligible for inclusion (figure 1). A total of 137 publications 
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from 129 RCTs, 4 gallstone disease- specific PROMs and 8t 
qualitative studies were therefore included
Sample characteristics of existing literature and new primary 
research
Existing literature
Seven studies were conducted in the UK. A further 44 were 
conducted in countries in Europe, other than the UK, 12 
in the USA and 66 in a range of other countries. A total 
of over 10 000 participants were included in the studies, 
predominantly women (sex ratio around 2.5:1) in their 
mid- 40s (40–53, median 46.1). Studies were mainly single- 
centre (n=113) and ranged in size from small (14 partic-
ipants) to large (618 participants) trials (median n=75). 
A vast majority of trials involved one type of surgery vs 
another type of surgery, with single incision laparoscopic 
cholecystectomy vs conventional laparoscopic cholecys-
tectomy being the most common trial configuration.22–71 
Other common configurations were early laparoscopic 
cholecystectomy versus delayed laparoscopic cholecystec-
tomy,72–87 mini laparoscopic cholecystectomy versus lapa-
roscopic cholecystectomy,88–97 mini laparotomy versus 
laparoscopic cholecystectomy98–103 and day- case laparo-
scopic cholecystectomy versus overnight stay laparoscopic 
cholecystectomy.104–107 There were few non- surgical inter-
ventions; one study compared shock wave lithotripsy and 
laparoscopic cholecystectomy,108 while several compared 
observation with cholecystectomy.109 110 The four disease 
specific PROMS for uncomplicated gallstone disease 
were developed in Canada (n=2), .New Zealand (n=1) 
and Germany (n=1).111–114 Two of the PROMS focused on 
gallstone disease,111 113 one on gastrointestinal diseases,114 
and the other on quality of life after abdominal surgery.112 
All of the PROMs reported to measure multidimensional 
constructs, for example, quality of life. The PROMs varied 
in the number of constructs they aimed to assess (ranging 
from 4-8) and the number of items they asked partici-
pants to report on (ranging from 5 to 41, median=27).
Figure 1 PRISMA systematic review diagram for evidence synthesis. PRISMA, Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses; PROMs, patient- reported outcome measures; RCTs, randomised controlled trial; SR, Systematic 
Reviews.
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The eight qualitative studies from seven different 
countries: USA (n=2),115 116 UK,117 Brazil,118 Canada,119 
Sweden,120 the Netherland121 and Spain122 were identi-
fied including 324 participants (ranged from 12 to 162, 
median=19.5). They were predominantly women and their 
age ranged from 19 to 81 years. Seven studies used inter-
views either face to face (n=5) or by telephone (n=2) and 
one used focus groups for data collection. All of the treat-
ments being explored in the studies were surgery but the 
types of surgery varied. Five studies investigated patients’ 
experiences after surgery, two investigated experiences of 
cholecystitis (ie, inflammation of the gall bladder) and 
surgery and another investigated experiences of cholelithi-
asis (ie, presence of gallstones).115–122 Table 1 provides a 
summary of the characteristics of participants included in 
the quantitative and qualitative literature review.
Primary research
Six individual interviews, one focus group (n=5 partic-
ipants) and analysis of 20 consultations (5 each from 4 
different hospital sites) were conducted providing data 
from a total sample of 31 patients. A brief description 
of the participants is provided in online supplemental 
appendix 2. They included 26 women and five men, 26 of 
whom had been approached to take part in the CGALL 
trial (12 trial consenters and 14 trial non- consenters), 
and 5 patients whom had not been approached about the 
trial but who had all had a cholecystectomy. The CGALL 
trial is an RCT comparing laparoscopic cholecystectomy 
with conservative management for preventing recurrent 
symptoms and complications in adults with uncompli-
cated symptomatic gallstones.18
Outcomes identified from existing literature and new primary 
research
A total of 386 individual recorded outcomes were identi-
fied across the combined evidence from existing literature 
and new primary research: 330 outcomes (which were 
reported 1147 times) from trials evaluating interventions, 
22 outcomes from PROMs, 17 outcomes from existing 
qualitative studies, and 17 outcomes from primary qual-
itative research.
Of the 330 individual outcomes reported in trials, 97 
(29.4%) were reported as ‘primary outcomes’ with only 
64 (19.4%) being formally defined and 227 (68.8%) 
were reported by one study only. The three ‘verbatim’ 
outcomes which were reported most frequently were: 
‘operating time’ (n=103), ‘postoperative pain’ (n=72) 
and ‘conversion to open surgery’ (n=71). In addition, 
two studies reported the outcome ‘conversion’. Four 
studies reported further outcomes relating to ‘operating 
time’, that is, ‘anaesthetic time’ (n=1), ‘surgical time’ 
(n=2), ‘procedure time’ (n=1). Forty studies reported 
further outcomes relating to pain: ‘umbilical pain’ (n=1), 
‘abdominal pain’ (n=9), right upper quadrant pain 
attacks’ (n=3), ‘chronic postsurgery pain’ (n=1), ‘overall 
pain’ (n=2), ‘incisional pain’ (n=10), ‘pain in the context 
of sexual intercourse’ (n=1), ‘Visual Analogue Pain 
Score’ (n=2), ‘pain’ (n=2), ‘shoulder pain’ (n=4), ‘pain 
or other symptoms in incision area/port sites’ (n=1), 
‘patient reported location of pain at initial postop visit’ 
(n=1), ‘site of most severe pain’ (n=1), ‘admission due to 
pain’ (n=2). Table 2 provides a list, and frequency, of all 
outcomes reported in the included trials.
Some 106 individual items were identified from the four 
gallstone disease specific PROMS covering 22 individual 
outcomes, with frequency of each outcome varying across 
the individual PROMs (table 3). Included PROMs covered 
between eight and 14 domains. None of the included 
PROMS reported whether patients were involved in the 
measures development. Pain and emotional outcomes 
were the most frequently covered with 17 items each 
(making up 32% of total items) and reported across all 
four PROMs. There were seven outcomes identified only 
once (and four of which were identified in one PROM) 
across the 106 items, which included thirst/dehydration, 
cognitive, service use, body image, sexual function, regur-
gitation and swallowing.





No of study 
participants
(n=119 studies) n=8 studies
Median 75 19.5
Range 14–618 6–100
Total 10 757 256
No of males/
females




Mean age (years) (n=14 studies) –
Median (years) 46.1 –
Range (years) 40–53 19–81








No of centres (n=129 studies) (n=8 studies)
Single centre 113 8
Multicentre 16
Total no of 
outcomes reported
330 17
*One study (Marks 2013) was conducted in the UK, USA and Italy 
and is included in the count for each country; number of studies 
(n=xx studies) in table relates to how many studies reported each 
relevant characteristic.
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Table 2 Outcomes reported in randomised controlled trials of interventions to treat uncomplicated gallstone disease
Domain Outcome No of times reported
Physical Physical activity postop 1
Recovery of self- reported physical activity 1
Time to resume normal physical activity 3
Time to resume walking 3
Functional impairment 1
Role Time to everyday life 1
Return to daily activities 1
Return to normal function 1
Return to activities of daily living 1
Days from surgery to normal activity 3
Time to return to normal activities 1
Days to full activity 1
No of days sick leave 3
Time away from work 2
Loss of active days of work 1
Time to return to work after discharge 1
Time to return to work 8
Days to return to school 1
Convalescence time 1
Postop regain of functionality 1
Total recuperation period 1
Mobilisation 1
Pain Overall pain 2
Pain 2
Visual analogue pain score 2
Site of most severe pain 1
Umbilical pain 1
Abdominal pain 9
Right upper quadrant pain attacks 3
Shoulder pain 4
Admission due to pain 2
Incisional pain 10
Whether had pain or other symptoms in incision 1
area/port sites
Patient- reported location of pain at initial postop 1
visit
Postoperative pain 72
Chronic post surgery pain 1
Analgesic requirements 58
Duration of analgesia use 2
Time to first analgesics 1
Days of medication required 1
Analgesia requirement 1
No of patients needing additional analgesia 1
Use of peripheral analgesics 1
Use of centrally acting analgesia 1
Continued
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Domain Outcome No of times reported
Total pethidine (mg) 1
Pethidine requirement 1
Suppository requests 1
Bowel movements Return of bowel function 1
Change in bowel habit 1
Diarrhoea or loose stools 2
Time to resume passing stools 1
Thirst/dehydration Resumption of oral diet within 24 hours 1
Resumption of orals 1
Resumption of oral intake 3
Normal drinking 1
Return to liquid feeds 1
Time to clear liquids 1
Appetite/eating/taste Time to resume eating 4
Normal eating 1
Return to solid diet 2
Time to resume feeding 1
Fatigue Fatigue 2
Sleep Length of night sleep 1
Awakening during the night 1
Generic health
Dietary habits
Overall health state 1
Health status 1




Global patient satisfaction 1
Patient overall satisfaction 1
Time interval between onset of symptoms and 1
admission to hospital
Need to avoid fried/fatty foods after surgery 3
Social Time away from recreational activity 1
Return to going out (days) 1
Belching/Bloating/Gas Time to resume passing intestinal gases 1
Flatulence and/or dyspepsia 1
Vomiting/nausea Nausea or vomiting 5
Vomiting 7
Nausea 8
Reflux Reflux symptoms 2
Regurgitation Heartburn or regurgitation 1
Heartburn or regurgitation 1
Body Image Satisfaction with body image 3
Patient derived body image 1
Satisfaction with aesthetic result 1
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Domain Outcome No of times reported
Satisfaction with cosmetic outcome 10
Incision satisfaction 1
Patient satisfaction score on surgery and scars 2
Cosmetic satisfaction of surgical scar 2
Patient satisfaction score on scars 1
Cosmetic outcome 13





Incision cosmetic result 1
Scar evaluation 4
Appearance of each incision 1
Sexual function Satisfaction in the context of sexual intercourse 1
Pain in the context of sexual intercourse 1
Dyspareunia 1
Generic symptoms Quality of life 22
Whether operation had had any impact on Quality of Life 1
Morbidity 8
Overall morbidity following diagnosis 1
General discomfort 1
Symptoms 1
Symptoms during waiting period 2
Residual abdominal symptoms 3
Examined for residual symptoms 1
Gastrointestinal complaints 1
Failure of conservative treatment 4
Failure of technique 1
No of patients recovered 1




Intraoperative adverse Common bile duct (CBD) stones 1




Bile duct injury 2
Bile spillage 1
Bile duct lesions 1
Haemorrhage 1
Blood loss 30
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Abdominal wall complications 1
Port- site complications 1
Tissue damage 1
Intra- abdominal collections 1
Postoperative adverse Postoperative complications 66
Events Parietal complications after surgery 2
Postoperative infection rate 1
Wound infection(s) 7
Rate of wound infection 1
Surgical site infection 1
Incision infection 1
Postoperative wound- related infection 1
Wound condition 1
Postoperative wound- related hernia 1
Porthernia 2
Postoperative hernia 1
Incisional hernia occurrence 6
Trocar herniation 2
Intra- abdominal adhesions 1
Satisfaction with surgery in general 1
Patient satisfaction score on surgery 2
Satisfaction with operation 5
Satisfaction with overall procedural result 1
Patient satisfaction after surgery 1
Perceived success of operation 1
Recommends the procedure 3
Patient preference survey including ‘willingness to pay for single incision 
laprascopic cholecystectomy’ questionnaire
1
Procedure believed to have undergone 1
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Domain Outcome No of times reported
Duration of each operative stage 1
Learning curve for operating time 1
Duration of admission 1
Hospital stay 60
Postoperative hospital stay 23
Day surgery 2
Successful completion of day surgery 3
Reasons for overnight stay in patients scheduled for 1
day surgery
Post Anaesthesia Care Unit length of stay 1
Discharge >24 hour postop 1
Discharge from hospital 1
Discharge from hospital 20–24 hours postoperative 1
Time until discharge 1
Time from operation to discharge 1
Grade of surgeon 1
Grade of operating surgeon 1
Resident’s participation 1
Need to contact hospital or other healthcare 2
providers after discharge
Ambulatory rate 1
No of patients requiring readmission to hospital 5
Readmission 3
Causes of hospitalisation 2





Conversion to open surgery 71
Conversion of 5–10 mm port 2
Modification of operative technique 4
Conversion to Laprascopic cholesytectomy (LC) 16
Conversion to Laproendoscopic single site procedure 1
Conversion to other laparoscopic approach 4
Conversion 2
Conversion from Single Incision Laprascopic Cholecystectomy (SILC) to 
4PLC (Four Port Laprascopic Cholecystectomy)
2
Rate of cholecystectomy 2
Table 2 Continued
Continued
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Domain Outcome No of times reported
Cost- effectiveness Cost of operation 6
Cost analysis 1
Procedural cost 1






Cost- effectiveness ratio 1
Economic analysis of early versus conventional 1
management for newly diagnosed GB disease
Process (operation or trial) Pulmonary function 5
Spirometric indices 1
Total carbon dioxide insufflation (litres) 1
Surgical stress response 2
No of cannulas used 1
Pressure of the pneumo peritoneum 1
Heart rate variability 1
Serum cytokines 1
Serum interleukin-6 3
Serum C reactive protein (CRP) 3
Blood count 1
Liver function tests 1
Alpha- defensins expression 1
hsCRP values 1
CRP values 1
Electroconductivity of representative dermatones 1





Occlusive bandages in place 1
General anaesthesia 1
Anaesthetic time 1
Amount of bupivacaine used 1
Length of skin incision 9
Extra skin incisions required 1
Aponeurosis wound size 1
Wound length 3
Scar length 2
Intraoperative cholangiography performed 3
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Domain Outcome No of times reported
Postop metabolic and hormonal levels 1
Postoperative level of 8- epiPGF2α 1
Postoperative level of uric acid 1
Postoperative forced expiratory volume in 1 s 1
Change of antibiotic therapy due to nonresponse or 1
To intolerance of moxifloxacin
Use of rescue therapy with 125 mg lysine clonixinate 1
Tablets
Time of surgical dissection 1
Time of closure 1
Detailed surgical time course 1
Rate of operative error 1
Technical problems 2
No of admissions between 8:00 and 17:00 hour 1
Admission on Monday to Thursday 1
Difficulty of case 2
Operative difficulty 1
Surgical difficulty 1
Difficulty of dissection 1
Difficulty (impaired) of exposure 1
Prediction of Laprascopic Cholecystectomy (LC) difficulty 1
Surgeon’s perceptions of difficulties during 1
operation
Potential for increased surgical risk to the patient 1
Critical view of safety 1
Assessment of surgical handling 1
Feasibility and safety of SILC versus 4PLC 1
Ultrasonography findings 1
No of stones 1
Size of largest stone 1
Rate of GB rupture 1
GB wall thickness 1
Time to retrieve GB 1
No and type of instruments 1
Use of extra umbilical rescue device 2.3 mm mini- LC 1
Instrument
Insertion points 1
No of incisions 1
Port sizes 1
Additional ports required 9
Port enlargement for GB removal 1
Additional trocars used 2
Fourth trocar added 2
Trocar use 1
Placement of any additional laparoscopic ports other 1
than the Single Incision and Transanal Surgery (SILS) port
Table 2 Continued
Continued
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Seventeen individual outcomes were identified from 
the existing qualitative literature (see table 4). Twelve 
overlapped with existing outcomes identified in the litera-
ture and the PROMS leaving five additional outcomes for 
consideration in the long list, namely: dizziness, fainting, 
trust, weight and prevention of additional disease.
The primary qualitative research identified 17 individual 
outcomes, with the majority (n=14) overlapping with 
those reported in the previously reviewed evidence (See 
table 4). However, three additional outcomes (breathing 
problems, cough and mortality) were identified that were 
not in the previous patient focused evidence (PROMs 
and qualitative literature), with two of these (breathing 
problems, cough) making unique contributions to the 
overall outcome list.
The 390 individual reported outcomes across the 4 data 
sources were reduced into a ‘short’ list of outcomes which 
could be measured in comparative effectiveness trials 
(ie, phase III pragmatic evections trials) of interventions 
to treat uncomplicated symptomatic gallstone disease 
(see table 5). This resulted in several outcomes being 
dropped from the long list as deemed not eligible as clin-
ical endpoint outcomes for use in trials of this type (eg, 
system and process outcomes such as duration of surgery 
which might be important in earlier phase trials). There-
fore, the final list covered 27 broad outcome domains 
Domain Outcome No of times reported
Time required for insertion of SILS port system 2
compared with four standard ports
Success rate (3- port vs 4- port LC) 2
Need to amplify extraction port 2
No of ports used 1
Reason for port placement 1
Time of trocar introduction 1
Use of Keith needle 1
Successful completion of needlescopic operation 1
No of drains placed 1
Requirement of drains 1
No of manual camera corrections 1
No of cleaning of the optics 1
Ability to achieve optimal focus on the operative site 1
During the procedure
Positioning accuracy of image 1
No of clearing camera 1
Time of adjusting operative field 1
Surgeon’s comfort 1
Comfort of instrument positioners 1
No of actions in positioning of laparoscope 1
Feasibility of surgical procedures using only the 1
camera robot
Commands misunderstood 1
No of commands issued by the surgeon 1
Sum of operative actions 1
No of dissection actions 1
No of grasping actions 1
Time from admission to ultrasonography 1
Time from ultrasonography to recruitment 1
Time from recruitment to operation 1
Time from recruitment to discharge 1
Completion of randomised treatment 2
Gallstone- associated events after randomisation 2
Table 2 Continued
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that contained 41 distinct outcomes. The domains of 
pain, intra- operative complications, and post- operative 
complications contained the most outcomes (n=4 each).
DISCUSSION
Currently, there is a lack of consistency in the selection, 
measurement and reporting of outcomes for uncom-
plicated gallstone disease. This leads to challenges in 
evidence synthesis and decision- making. A Core Outcome 
Set would be an important step to improve this situation. 
This paper which describes an outcome mapping exercise 
is the first comprehensive step in the development of a 
core outcome set. It catalogues and reports the outcomes 
that have been measured in trials of interventions to 
treatment uncomplicated gallstone disease. It extends 
this initial phase of outcome identification to include 
outcomes from PROMs, published qualitative evidence 
and empirical qualitative research. Over 1000 verbatim 
outcomes were identified and reduced through dedupli-
cation to 390. This was further reduced to 41 outcomes 
spanning 27 domains. The next steps in this work are to 
reach consensus for the COS for uncomplicated symp-
tomatic gall stone disease.
As with many other outcome mapping exercises, this 
first stage of this study highlights the significant hetero-
geneity that exists within clinical trials comparing treat-
ments for gallstone disease. Of the 334 outcomes, which 
were reported multiple times across the 129 RCTs, 
almost 70% were reported by only one study—a finding 
comparable with other outcome mapping studies.21 123 124 
All of the effort into collection and reporting of these 
outcomes is likely wasted as it is doubtful that they could 
be combined with others to make more confident assess-
ment of the effectiveness of treatments. This outcome 
heterogeneity in existing trials is further emphasised 
when considering the outcome of pain, which is reported 
in 72 trials as postoperative pain but also reported in a 
number of other trials using 15 different outcomes. The 
four disease specific PROMs identified further extend 
the problem of outcome heterogeneity. While all of these 
measures report to capture quality of life, there is vari-
ability in both the inclusion and emphasis of domains 
Table 3 Inclusion of domains across included PROMs ranked by frequency of domains
Domain (n=22) No items per domain ASIS112 CSQ113 GIC111 GIQLI114 Total
Emotional 17 ✓ ✓ ✓ ✓ 4
Pain 17 ✓ ✓ ✓ ✓ 4
Role 11 ✓ ✓ 2
Bowel movements 8 ✓ ✓ 2
Belching/bloating/gas 7 ✓ ✓ 2
Appetite/eating/taste 6 ✓ ✓ ✓ 3
Dietary habits 6 ✓ ✓ 2
Physical 6 ✓ ✓ 2
Fatigue 5 ✓ ✓ ✓ ✓ 4
Social 4 ✓ ✓ ✓ 3
Sleep 3 ✓ ✓ 2
Stomach problems 3 ✓ ✓ 2
Generic health 2 ✓ ✓ 2
Reflux 2 ✓ 1
Vomiting/nausea 2 ✓ 1
Body image 1 ✓ 1
Cognitive 1 ✓ 1
Dysphagia/swallowing 1 ✓ 1
Regurgitation 1 ✓ 1
Service use 1 ✓ 1
Sexual function 1 ✓ 1
Thirst/dehydration 1 ✓ 1
Total 106 10 8 11 14
ASIS, Abdominal Surgery Impact Scale; CSQ, Otago gallstone condition specific questionnaire; GIC, Gallstone Impact Checklist; GIQLI, 
Gastrointestinal Quality of Life Index; PROMs, patient- reported outcome measures.
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captured across each of the tools. For example, the most 
frequently covered domains capture emotion and pain 
and are reported across all four tools. Fatigue is also 
reported across all four tools but is only captured by five 
items as opposed to the 17 each for emotion and pain. 
Nine of the 22 domains are only captured by one of the 
PROMs, with a further eight domains being captured by 
2 PROMs. Again this variability in what individual items 
are measured in these tools and how they contribute to 
overall ‘quality of life’ assessments, raises questions about 
the legitimacy of combining these measures when eval-
uating intervention effectiveness. In addition, the rele-
vance of these outcomes to patients must be called into 
question given the lack of reporting of input from patients 
in the item inception phase of PROM design across these 
measures. Two reviews published after completion of this 
work conducted an methodological assessments of both 
disease specific and generic PROMs for laparoscopic 
cholecystectomy and both report considerable variation 
and a lack of patient involvement.125 126 There are now 
several reviews of PROMs in other clinical specialties that 
also provide findings which further highlight the hetero-
geneity that exists across measures which, on the surface, 
report to measure similar concepts.20 127–129
The different evidence sources contributed to the 
final outcome short list in a variety of ways with the 
outcomes reported in previous trials often capturing 
clinically focused endpoints and the PROMS and qualita-
tive research providing more patient focused outcomes. 
When considering what outcomes matter to patients 
and how this contributes to the outcome mapping in 
this area, this study used two approaches to ensure 
patient relevant outcomes were included. The qualita-
tive evidence synthesis and primary research identified a 
total of 34 combined (of which 21 were mutually exclu-
sive) outcomes, that were important to patients in terms 
of their gallstone disease or their perceptions about treat-
ments. Theses outcomes could be broadly grouped into 
physical and social functioning with most reports from 
participants focusing on reduction in pain and a desire 
to ‘return to normal’. When compared with the outcome 
domains reported in the PROMs, there was consider-
able overlap between the two sources. However, there 
were some areas of discordance between the different 
sources, with the qualitative data adding a further eight 
outcomes. In addition the qualitative evidence synthesis 
and the empirical research identified outcomes not previ-
ously measured or reported in comparative effectiveness 
trials for uncomplicated gallstone disease. This value of 
including evidence from existing literature exploring 
patients perspective and/or new primary research to 
identify patient relevant outcomes is gaining traction 
among COS developed.5 Where most have included 
outcomes through identification in interviews, the use of 
qualitative evidence synthesis is growing, and especially 
in areas where there has previously been a consider-
able volume of work to draw on.130 These studies have 
shown that this work contributes previously unreported 
outcomes that are of importance to patients and hence 
underpins the critical nature of this step in COS devel-
opment. Whether these outcomes identified in these 
list development stages end up making it into the COS 
Table 4 Outcomes reported in PROMs, qualitative 






Emotional ✓ ✓ ✓
Pain ✓ ✓ ✓
Role ✓ ✓







Dietary habits ✓ ✓ ✓
Physical ✓
Fatigue ✓ ✓ ✓
Social ✓ ✓ ✓
Sleep ✓ ✓ ✓
Stomach problems ✓ ✓ ✓
Generic health ✓
Reflux ✓ ✓ ✓


























PROMs, patient- reported outcome measures.
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is currently less well evidenced but will be important to 
know.
Strengths and limitations
This outcome mapping exercise used a systematic search 
to identify outcomes reported in both quantitative and 
qualitative studies in the literature. In addition to this 
rigorous systematic search we supplemented the pool of 
outcomes already available with new primary qualitative 
research (through three methods) to further identify 
outcomes that matter to patients who are experiencing 
uncomplicates symptomatic gallstone disease. This 
complementary approach to identification of outcomes 
has ensured a broad catalogue of both clinically rele-
vant and patient important outcomes. Limitations of this 
review are linked to the inclusion of only English language 
studies, a lack of quality appraisal of included studies, and 
no assessment of reporting bias. While these decisions 
were fit for purpose for the COS activity, they may have 
introduced potential reporting and selection bias within 
the outcome map. With regard to outcome reporting 
bias, other COS development papers have explored this 
and found that in surgical studies of oesophagectomy 
and colorectal cancer resection papers frequently did not 
report all the outcomes intended to be measured (50% 
at least or more did not do that).131 132 Future COS devel-
opment studies should consider this approach to assess 
outcome reporting bias. It would also have been useful to 
collect the study teams reported rationale for the selec-
tion of reported outcomes to determine how that process 
was determined.
CONCLUSIONS
This study took a rigorous approach to catalogue and 
map the outcomes of importance in gallstone disease 
to enhance the development of the COS ‘long’ list. The 
synthesis of data from the four different evidence sources 
further underpinned the need for a COS in this space 
due to the heterogeneity of outcome measurement and 
reporting. However, the extensive use of data sources to 
contribute to the development of the list of outcomes 
for further consensus agreement, did highlight ‘new’ 
outcomes that have not been previously reported for trials 
evaluating interventions for gallstone disease and many 
of these ‘new’ outcomes were those reported by patients. 
This comprehensive approach to the development of the 
long list, and then ultimately the short list for scoring in 
a COS, gives confidence that both clinically relevant and 
patient focused outcomes have been considered and have 
the potential to be represented in the agreed COS.
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